ArticleCell communication and signaling : CCS2023

Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.

Josh T Coats et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.